Brief: Healius Says Volume Growth In Pathology Has Continued During July And August
Aug 21 (Reuters) - Healius HLS.AX :
* VOLUME GROWTH IN PATHOLOGY HAS CONTINUED DURING JULY AND
AUGUST,
IMPROVING BY OVER 4% ON PCP
* INTENT ON RESUMING DIVIDENDS AS SOON AS PRACTICABLE
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028